A Story of Migration of a Surgically Implanted Aortic Sutureless Valve

Amir, Alexander; Moore, Albert; Carvalho, George; Codère-Marayuma, Takumi; Schricker, Thomas; Villeneuve, Valérie; Hatzakorzian, Roupen

doi:10.1053/j.jvca.2017.06.038

Cited by 1 publication

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…BAV has been considered a contraindication for the implantation of the SURD valve, as it is often associated with altered geometric root, sinus asymmetry, elliptic annulus and different commissural heights. In addition, some cases of migration and dislocation have been reported at follow-up, suggesting some words of caution in using these prostheses in BAV (11,12,14). An international expert consensus panel recommends the use of CT scan in defining the anatomical root geometry for evaluating aortic annulus, sinotubular junction and leaflet morphology (15).…”

Section: Discussionmentioning

confidence: 99%

“…However, in the setting of BAV, these benefits are less clear. Despite several studies demonstrating good clinical outcomes, some reports suggest that SURD valves may increase the risk of paravalvular regurgitation and/or potential dislocation related to BAV aortic root asymmetry (8)(9)(10)(11)(12). Therefore, the aim of our study is to report the outcomes of patients undergoing AVR with SURD valves in patients with BAV from the Sutureless and Rapid-Deployment Aortic Valve Replacement International Registry (SURD-IR).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Sutureless and rapid deployment implantation in bicuspid aortic valve: results from the sutureless and rapid-deployment aortic valve replacement international registry

Miceli¹,

Berretta²,

Fiore³

et al. 2020

Ann Cardiothorac Surg

View full text Add to dashboard Cite

Background: Benefits of sutureless and rapid deployment (SURD) bioprostheses in bicuspid aortic valves (BAV) are controversial. The aim of this study is to report the outcomes of patients undergoing aortic valve replacement (AVR) for BAV from the Sutureless and Rapid-Deployment Aortic Valve Replacement International Registry (SURD-IR). Methods: Of the 4,636 patients who received primary isolated SURD-AVR between 2007 and 2018, 191 (4.1%) BAV patients underwent AVR with SURD valve. Results: Overall 30-day mortality was 1.6%. The Intuity valve was implanted in 53.9% of cases, whereas the Perceval was implanted in 46.1%. Rate of stroke for isolated AVR was 4.2%. No case of endocarditis, thromboembolism, myocardial infarction, valve dislocation or structural valve deterioration was reported in the early phase. Rate of pacemaker implantation and moderate-severe aortic regurgitation (AR) were 7.9% and 3.7%, respectively. Conclusions: BAV is not considered a contraindication for the implantation of SURD valves. However, detailed information of aortic root geometry as well as the knowledge of some technical considerations are mandatory for a good outcome.

show abstract